Hypertrophic cardiomyopathy screening
Hypertrophic cardiomyopathy screening | |
---|---|
Purpose | Detect and prevent sudden cardiac death, reduce complications of hypertrophic cardiomyopathy[1] |
Hypertrophic cardiomyopathy screening is an assessment and testing to detect hypertrophic cardiomyopathy (HCM).[1][2]
It is a way of identifying HCM in immediate relatives of family members diagnosed with HCM, and
Purpose
HCM is a
Screening
Generally, screening may be considered for anyone of any age with a family history of HCM or sudden death.
The American Heart Association have developed a 14-point evaluation for competitive athletes, which it recommends for screening healthy teenagers and young adults.[4]
-
Flight medical: listening of the chest
-
ECG of an athlete
-
Child having echocardiogram
Pre-participation Screening
In a few well-trained athletes, the normal 10% to 20% increase in left ventricular wall thickness may make it less easy to differentiate an
Particularly for black athletes, some of their ECG characteristics are more likely to cross over with those seen in HCM.
Physical Exam Findings
There are some physical exam findings that can alert you to look further for HCM. Though some patients can be asymptomatic, it is helpful to associate certain findings with a greater chance of HCM being present. The murmur heard in HCM (or HOCM, if obstructive) is a systolic ejection crescendo-decrescendo murmur. The intensity of this murmur can vary based on the degree of obstruction. This murmur can also change in intensity based on different maneuvers that can be accomplished with the body. The murmur will decrease with maneuvers that cause an increase in preload, such as squatting. It will also decrease with maneuvers that increase afterload, such as hand grip. Conversely, the murmur will increase with maneuvers that decrease preload, such as Valsalva, giving diuretics, and standing. A holosystolic murmur heard at the apex or axilla can indicate mitral regurgitation, which can be found in patients with HCM. Other physical exam findings that may be present are a jugular venous pulse with a prominent A wave, an S4 heart sound, and split second heart sounds with severe disease and prominent outflow tract obstruction. [9]
Global variation
HCM has traditionally been of greater interest in Europe, North America, Japan, Israel, and Australia.[10]
Research directions
As of 2020, research on heart adaptations in females, teenagers and Asian populations is required.[3]
References
- ^ S2CID 238217008.
- ^ S2CID 227156559.
- ^ PMID 32944090.
- ^ ISBN 978-3-030-69383-1.
- ^ ISBN 978-3-030-24176-6.
- ^ Norrish G, Jager J, Field E, Quinn E, Fell H, Lord E, Cicerchia MN, Ochoa JP, Cervi E, Elliott PM, Kaski JP. Yield of Clinical Screening for Hypertrophic Cardiomyopathy in Child First-Degree Relatives. Circulation. 2019 Jul 16;140(3):184-192. doi: 10.1161/CIRCULATIONAHA.118.038846. Epub 2019 Apr 22. PMID: 31006259; PMCID: PMC6636798.
- PMID 35813032.
- PMID 33154912.
- ^ Raj MA, Ranka S, Goyal A. Hypertrophic Obstructive Cardiomyopathy. [Updated 2022 Oct 31]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430820/
- PMID 25038775.